Mirum Pharmaceuticals MIRM
$96.13 +$0.62 (+0.65%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $96.13 0.00%
Open$94.50
Prev close$95.51
Day range$94.10 – $98.39
Volume1.06M
Market cap$6.28B
P/E (TTM)–
Dividend yield–
MIRM Stock News
Headlines matching Mirum Pharmaceuticals or the MIRM ticker, most recent first.
- Baird Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Raises Target Price to $130 Positive
- H.C. Wainwright Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $195
- Citi Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $160
- A Quick Look at Today's Ratings for Mirum Pharmaceuticals(MIRM.US), With a Forecast Between $130 to $195
- J.P. Morgan Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating
- Analysts Are Bullish on These Healthcare Stocks: Maze Therapeutics, Inc. (MAZE), Mirum Pharmaceuticals (MIRM) Positive
- Citi Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $145
- A Quick Look at Today's Ratings for Mirum Pharmaceuticals(MIRM.US), With a Forecast Between $118 to $140
- J.P. Morgan Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Cuts Target Price to $118 Negative
- A Quick Look at Today's Ratings for Mirum Pharmaceuticals(MIRM.US), With a Forecast Between $135 to $140
- H.C. Wainwright Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $185
- H.C. Wainwright Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $140
- J.P. Morgan Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $118
- J.P. Morgan Keeps Their Buy Rating on Mirum Pharmaceuticals (MIRM)
- TD Cowen Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $140
No comments yet — be the first to weigh in on MIRM.
Sign in to join the discussion.